Last Price$155.4(2.4%)
Market Cap$8,979.7M
LTM Gross margin
46.9%
5Y avg
54.1%
Medical - Instruments & Supplies industry
median
48.7%
Stock quality & Intrinsic value
6/10
(0.8%) overvalued
Repligen Corporation Gross margin
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 53.0% | 58.5% | 72.5% | 74.3% | 68.1% | 76.9% | 73.7% | 73.9% | 56.4% | 63.1% | 55.9% | 57.8% | 54.9% | 52.5% | 55.7% | 55.9% | 57.2% | 58.3% | 56.9% | 48.8% |
Overvalued or undervalued?
Check the intrinsic value for RGEN
and see if it's the right time to invest.
Repligen Corporation (RGEN) Gross margin comparison analysis
General
LTM Gross margin
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Repligen CorporationRGEN
46.9%
(21.1%)
(80.9%)
5.6%
Median Peer Set
55.9%
3.4%
23.0%
10.4%
Intuitive Surgical, Inc.ISRG
67.5%
17.2%
27.7%
27.8%
The Cooper Companies, Inc.COO
62.8%
8.4%
32.2%
10.1%
Becton, Dickinson and CompanyBDX
59.4%
4.2%
18.3%
8.4%
ResMed Inc.RMD
57.9%
10.9%
13.4%
21.8%
Hologic, Inc.HOLX
56.2%
(0.0%)
81.1%
19.6%
Alcon Inc.ALC
55.6%
8.5%
182.9%
10.3%
AptarGroup, Inc.ATR
48.7%
2.7%
30.2%
10.5%
Masimo CorporationMASI
48.0%
0.6%
(42.5%)
4.0%
Baxter International Inc.BAX
37.1%
(69.5%)
(100.0%)
(6.9%)
West Pharmaceutical Services, Inc.WST
34.6%
(1.9%)
(15.5%)
17.0%
RGEN key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 6.9 0.0% | 9.4 35.4% | 12.9 37.9% | 14.1 9.0% | 19.3 37.1% | 29.4 52.2% | 21.0 (28.6%) | 27.3 30.1% | 62.3 128.2% | 68.2 9.5% | 63.5 (6.8%) | 83.5 31.5% | 104.5 25.1% | 141.2 35.1% | 194.0 37.4% | 270.2 39.3% | 366.3 35.5% | 670.5 83.1% | 801.5 19.5% | 632.4 (21.1%) |
| Cost of Goods Sold (COGS) | 3.2 | 3.9 | 3.6 | 3.6 | 6.2 | 6.8 | 5.5 | 7.1 | 27.2 | 25.2 | 28.0 | 35.3 | 47.1 | 67.1 | 86.0 | 119.1 | 156.6 | 279.3 | 345.8 | 323.5 |
% margin | 3.7 53.0% | 5.5 58.5% | 9.4 72.5% | 10.5 74.3% | 13.1 68.1% | 22.6 76.9% | 15.5 73.7% | 20.2 73.9% | 35.1 56.4% | 43.0 63.1% | 35.5 55.9% | 48.3 57.8% | 57.4 54.9% | 74.2 52.5% | 108.1 55.7% | 151.1 55.9% | 209.6 57.2% | 391.3 58.3% | 455.7 56.9% | 308.8 48.8% |
| Operating Expenses | 13.6 | 9.6 | 10.6 | 12.3 | (22.8) | 18.7 | 21.2 | 20.5 | 23.7 | 20.0 | 22.8 | 30.4 | 38.2 | 60.2 | 82.1 | 115.1 | 139.8 | 218.1 | 259.8 | 261.1 |
| Research & Development Expenses (R&D) | 6.5 | 5.0 | 5.2 | 5.9 | 7.2 | 12.8 | 14.2 | 12.5 | 10.5 | 7.3 | 5.6 | 5.7 | 7.4 | 8.7 | 15.8 | 19.5 | 20.2 | 34.3 | 43.9 | 42.7 |
| Selling, General & Administrative Expenses (SG&A) | 4.7 | 4.6 | 5.4 | 6.4 | 10.2 | 5.9 | 7.1 | 8.0 | 13.2 | 12.7 | 17.2 | 24.7 | 30.9 | 51.5 | 66.3 | 95.6 | 119.6 | 183.9 | 215.8 | 216.9 |
% margin | (9.9) (143.8%) | (4.2) (44.5%) | (1.2) (9.4%) | (1.8) (13.0%) | 35.9 186.0% | 3.9 13.2% | (5.8) (27.5%) | (0.4) (1.4%) | 11.1 17.8% | 22.9 33.6% | 10.7 16.8% | 13.8 16.5% | 16.0 15.3% | 14.0 9.9% | 26.0 13.4% | 14.9 5.5% | 42.5 11.6% | 133.5 19.9% | 133.6 16.7% | 47.7 7.5% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.3 | 1.7 | 0.2 | 7.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 3.8 | 6.4 | 6.7 | 9.3 | 12.1 | 12.7 | 1.2 | 10.0 |
| Pre-tax Income | (9.6) | (3.0) | 0.7 | (0.9) | 37.9 | 5.8 | (4.9) | (0.0) | 11.3 | 23.0 | 11.1 | 13.4 | 11.7 | 7.2 | 21.4 | 26.2 | 59.2 | 153.5 | 219.1 | 56.7 |
% effective tax rate | 9.6 (100.0%) | 3.0 (100.0%) | (0.7) (100.0%) | 0.9 (100.0%) | 0.8 2.2% | 0.0 0.5% | (0.8) 17.0% | (0.3) 759.8% | (2.9) (25.6%) | 6.9 30.1% | 3.0 26.6% | 4.1 30.4% | 0.0 0.1% | (21.1) (291.2%) | 4.8 22.5% | 4.7 18.1% | (0.7) (1.2%) | 25.3 16.4% | 33.2 15.1% | 21.1 37.2% |
% margin | (9.6) (138.1%) | (3.0) (31.9%) | 0.7 5.4% | (0.9) (6.3%) | 37.1 192.3% | 5.7 19.6% | (4.1) (19.4%) | (0.0) (0.2%) | 14.2 22.7% | 16.1 23.6% | 8.2 12.9% | 9.3 11.2% | 11.7 11.2% | 28.4 20.1% | 16.6 8.6% | 21.4 7.9% | 59.9 16.4% | 128.3 19.1% | 186.0 23.2% | 35.6 5.6% |
| EPS | (0.32) | (0.10) | 0.02 | (0.03) | 1.20 | 0.19 | (0.13) | (0.00) | 0.46 | 0.51 | 0.25 | 0.28 | 0.35 | 0.74 | 0.38 | 0.44 | 1.14 | 2.33 | 3.35 | 0.64 |
| Diluted EPS | (0.32) | (0.10) | 0.02 | (0.03) | 1.18 | 0.18 | (0.13) | (0.00) | 0.45 | 0.50 | 0.25 | 0.28 | 0.34 | 0.72 | 0.37 | 0.44 | 1.11 | 2.24 | 3.24 | 0.63 |
% margin | (2.2) (32.2%) | (1.2) (13.0%) | (1.8) (14.1%) | 36.7 260.9% | 6.9 35.5% | (3.5) (12.0%) | 1.7 7.9% | (0.0) (0.1%) | 14.8 23.8% | 26.1 38.3% | 15.2 23.9% | 22.4 26.9% | 24.6 23.5% | 24.1 17.1% | 41.8 21.5% | 58.4 21.6% | 101.6 27.7% | 211.6 31.6% | 246.9 30.8% | 127.8 20.2% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Repligen Corporation's Gross margin?
As of today, Microsoft Corp's last 12-month Gross margin is 46.9%, based on the financial report for Sep 30, 2024 (Q3’2024). The average annual Gross margin for Repligen Corporation have been 53.1% over the past three years, and 56.8% over the past five years.
2) Is Repligen Corporation's Gross margin Good?
As of today, Repligen Corporation's Gross margin is 46.9%, which is lower than industry median of 48.7%. It indicates that Repligen Corporation's Gross margin is Bad.